Antiphospholipid antibodies are not elevated in patients with severe COVID-19 pneumonia and venous thromboembolism

Thumbnail Image

Download

SAF y covid 2020.pdf (421.62 KB)

Official URL

https://doi.org/10.1016/j.thromres.2020.05.017

Full text at PDC

Publication date

2020

Authors

Advisors (or tutors)

Editors

Journal Title

Journal ISSN

Volume Title

Publisher

Elservier
Citations
Google Scholar
Exportar
DC QDC MarcXML RDF MODS METS ORE-ATOM

URI

https://hdl.handle.net/20.500.14352/129428

Citation

Galeano-Valle F, Oblitas CM, Ferreiro-Mazón MM, Alonso-Muñoz J, del-Toro-Cervera J, Demelo-Rodríguez P. Antiphospholipid antibodies are not elevated in patients with severe COVID-19 pneumonia and venous thromboembolism. Thromb Res. 2020;192:113-115. doi: 10.1016/j.thromres.2020.05.017. Epub 2020 May 15.

Abstract

COVID-19 pneumonia could be associated with an increased risk of venous thrombosis. Antiphospholipid antibodies might be involved in thrombosis in COVID-19 patients. Prevalence of antiphospholipid antibodies in COVID-19 and venous thrombosis was low.

Research Projects

Organizational Units

Journal Issue

Description

UCM subjects

Ciencias Biomédicas

Unesco subjects

32 Ciencias Médicas

Keywords

Collections

Artículos